Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry-Reference-Cited by-同舟云学术

Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry

Published:2024-05-07 Issue: Volume: Page:
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Stölzl D.¹^ORCID,Sander N.¹^ORCID,Siegels D.²^ORCID,Harder I.¹^ORCID,Kind B.²^ORCID,Fonfara M.¹^ORCID,Heinrich L.²^ORCID,Ott Hagen³,Abraham S.⁴,Neustädter I.⁵,Kleinheinz A.⁶,Gerdes S.¹,Wollenberg A.⁷⁸,Lau S.⁹^ORCID,Nemat K.¹⁰,Heratizadeh A.¹¹,Gellhaus I.¹²,Werfel T.¹¹^ORCID,Schmitt J.²^ORCID,Weidinger S.¹^ORCID,

Affiliation:

1. Department of Dermatology and Allergy University Hospital Schleswig‐Holstein Campus Kiel Germany

2. Center for Evidence‐Based Healthcare University Hospital Carl Gustav Carus, Technical University Dresden Germany

3. Department of Pediatric Dermatology Children’s Hospital Auf Der Bult, Academic Hospital Hannover Germany

4. Department of Dermatology University Hospital Carl Gustav Carus, Technical University Dresden Dresden Germany

5. Cnopfsche Children's Hospital/Neonatology, Pediatrics, DIAKONEO KdöR Nuremberg Germany

6. Clinics for Dermatology Elbe Klinikum Buxtehude Buxtehude Germany

7. Clinics and Outpatient Clinics for Dermatology and Allergy LMU Munich Munich Germany

8. Department of Dermatology and Allergy University Hospital Augsburg Augsburg Germany

9. Pediatric Respiratory Medicine, Immunology and Critical Care Medicine Charité Universitätsmedizin Berlin Berlin Germany

10. Praxis für Kinderpneumologie/Allergologie Kinderzentrum Dresden‐Friedrichstadt Dresden Germany

11. Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy Hannover Medical School Hannover Germany

12. Rehaforschung Nord e.V Sylt Germany

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.16147

Reference6 articles.

1. Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry

2. Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the BioDay registry

3. Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: A systematic review and meta‐analysis

4. Staphylococcal Adhesion and Host Cell Invasion: Fibronectin-Binding and Other Mechanisms

5. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention